Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza and Acute Respiratory Viral Infections”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableWithdrawnNCT06163677
What this trial is testing

Look at the Health Outcomes of Patients With COVID-19 and Influenza.

Who this might be right for
COVID-19Coronavirus Disease 2019Influenza
Pfizer
Not applicableStudy completedNCT05084846
What this trial is testing

InFLUenza and the HEART An Investigation Into the Acute and Lasting Cardiac Effects of Influenza Infection

Who this might be right for
InfluenzaCardiovascular Complication
University Hospital, Gentofte, Copenhagen 241
Large-scale testing (Phase 3)Study completedNCT02644018
What this trial is testing

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o.

Who this might be right for
Common ColdInfluenza
Valenta Pharm JSC 190
Early research (Phase 1)Study completedNCT03459391
What this trial is testing

Study to Assess Safety, Tolerability and Pharmacokinetics of XC221 in Healthy Volunteers

Who this might be right for
InfluenzaAcute Respiratory Infection
PHARMENTERPRISES LLC 32
Post-approval studies (Phase 4)Study completedNCT03301155
What this trial is testing

Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other ARVI

Who this might be right for
Preventive Medicine
Materia Medica Holding 1,036
Not applicableStudy completedNCT05080933
What this trial is testing

ECMO for COVID-19 vs Influenza A H1N1 Associated ARDS

Who this might be right for
ARDSCOVID-19H1N1 Influenza
University of Turin, Italy 308
Post-approval studies (Phase 4)Study completedNCT00981513
What this trial is testing

Direct and Indirect Benefits of Influenza Vaccination in Schools and Households

Who this might be right for
Influenza Virus InfectionInfluenza-like IllnessAcute Respiratory Infection
The University of Hong Kong 6,300
Testing effectiveness (Phase 2)Study completedNCT04736758
What this trial is testing

A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza

Who this might be right for
Influenza
Jiangxi Qingfeng Pharmaceutical Co. Ltd. 216
Testing effectiveness (Phase 2)Study completedNCT02867358
What this trial is testing

A Clinical Trial of KT07 Capsule in the U.S.A

Who this might be right for
Influenza, Human
Yiling Pharmaceutical Inc. 391
Testing effectiveness (Phase 2)Looking for participantsNCT05735717
What this trial is testing

MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies

Who this might be right for
Hematologic MalignancyAcute LeukemiaRemission+21 more
Masonic Cancer Center, University of Minnesota 70
Not applicableStudy completedNCT04748445
What this trial is testing

Acute Respiratory Illness Surveillance (AcRIS) With Mobile Application in a Low-Interventional Decentralized Study.

Who this might be right for
Healthy
Pfizer 9,151
Not applicableLooking for participantsNCT07359287
What this trial is testing

Impact of a Multimodal Intervention on Antibiotic Prescribing for Respiratory Infections in Primary Care

Who this might be right for
AnginaAcute BronchiolitisAcute Bronchitis+8 more
University Hospital, Caen 4,500
Large-scale testing (Phase 3)WithdrawnNCT04848467
What this trial is testing

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older

Who this might be right for
SARS-CoV-2 InfectionCoronavirus Disease 2019 (COVID-19)
Bayer
Not applicableUnknownNCT05946538
What this trial is testing

Clinical Evaluation of SARS-COV-2 (COVID-19), Influenza and RSV 8-Well MT-PCR Panel for In Vitro Diagnostics

Who this might be right for
Respiratory Viral Infection
AusDiagnostics Pty Ltd. 1,000
Large-scale testing (Phase 3)WithdrawnNCT00486980
What this trial is testing

Intramuscular Peramivir for the Treatment of Uncomplicated Influenza

Who this might be right for
Influenza
BioCryst Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT05030324
What this trial is testing

Evaluate the Safety, Tolerability and Efficacy of XC221 in Patients With Uncomplicated Influenza or Other Acute Viral Upper Respiratory Infections

Who this might be right for
InfluenzaViral Respiratory InfectionAcute Viral Upper Respiratory Infections
Valenta Pharm JSC 255
Large-scale testing (Phase 3)Ended earlyNCT00610935
What this trial is testing

Intramuscular Peramivir in Subjects With Uncomplicated Acute Influenza

Who this might be right for
Influenza
BioCryst Pharmaceuticals 82
Not applicableUnknownNCT05612893
What this trial is testing

Discover the Immune Signature of Sepsis Caused by Acute Pulmonary Infection: A Cohort Study

Who this might be right for
SepsisViral PneumoniaInfluenza+1 more
Capital Medical University 1,000
Testing effectiveness (Phase 2)Study completedNCT03830905
What this trial is testing

Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI

Who this might be right for
InfluenzaAcute Respiratory Viral Infections
PHARMENTERPRISES LLC 120
Testing effectiveness (Phase 2)Study completedNCT04610047
What this trial is testing

Efficacy and Safety of Norketotifen in Uncomplicated Influenza-like Illness

Who this might be right for
InfluenzaInfluenza -Like Illness
Emergo Therapeutics, Inc. 315
Next Page